X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
75
PharmaCompass offers a list of Galantamine Hydrobromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Galantamine Hydrobromide manufacturer or Galantamine Hydrobromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Galantamine Hydrobromide manufacturer or Galantamine Hydrobromide supplier.
PharmaCompass also assists you with knowing the Galantamine Hydrobromide API Price utilized in the formulation of products. Galantamine Hydrobromide API Price is not always fixed or binding as the Galantamine Hydrobromide Price is obtained through a variety of data sources. The Galantamine Hydrobromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Galantamine Hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Galantamine Hydrobromide, including repackagers and relabelers. The FDA regulates Galantamine Hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Galantamine Hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Galantamine Hydrobromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Galantamine Hydrobromide supplier is an individual or a company that provides Galantamine Hydrobromide active pharmaceutical ingredient (API) or Galantamine Hydrobromide finished formulations upon request. The Galantamine Hydrobromide suppliers may include Galantamine Hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Galantamine Hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Galantamine Hydrobromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Galantamine Hydrobromide active pharmaceutical ingredient (API) in detail. Different forms of Galantamine Hydrobromide DMFs exist exist since differing nations have different regulations, such as Galantamine Hydrobromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Galantamine Hydrobromide DMF submitted to regulatory agencies in the US is known as a USDMF. Galantamine Hydrobromide USDMF includes data on Galantamine Hydrobromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Galantamine Hydrobromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Galantamine Hydrobromide suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Galantamine Hydrobromide Drug Master File in Japan (Galantamine Hydrobromide JDMF) empowers Galantamine Hydrobromide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Galantamine Hydrobromide JDMF during the approval evaluation for pharmaceutical products. At the time of Galantamine Hydrobromide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Galantamine Hydrobromide suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Galantamine Hydrobromide Drug Master File in Korea (Galantamine Hydrobromide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Galantamine Hydrobromide. The MFDS reviews the Galantamine Hydrobromide KDMF as part of the drug registration process and uses the information provided in the Galantamine Hydrobromide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Galantamine Hydrobromide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Galantamine Hydrobromide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Galantamine Hydrobromide suppliers with KDMF on PharmaCompass.
A Galantamine Hydrobromide CEP of the European Pharmacopoeia monograph is often referred to as a Galantamine Hydrobromide Certificate of Suitability (COS). The purpose of a Galantamine Hydrobromide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Galantamine Hydrobromide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Galantamine Hydrobromide to their clients by showing that a Galantamine Hydrobromide CEP has been issued for it. The manufacturer submits a Galantamine Hydrobromide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Galantamine Hydrobromide CEP holder for the record. Additionally, the data presented in the Galantamine Hydrobromide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Galantamine Hydrobromide DMF.
A Galantamine Hydrobromide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Galantamine Hydrobromide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Galantamine Hydrobromide suppliers with CEP (COS) on PharmaCompass.
A Galantamine Hydrobromide written confirmation (Galantamine Hydrobromide WC) is an official document issued by a regulatory agency to a Galantamine Hydrobromide manufacturer, verifying that the manufacturing facility of a Galantamine Hydrobromide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Galantamine Hydrobromide APIs or Galantamine Hydrobromide finished pharmaceutical products to another nation, regulatory agencies frequently require a Galantamine Hydrobromide WC (written confirmation) as part of the regulatory process.
click here to find a list of Galantamine Hydrobromide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Galantamine Hydrobromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Galantamine Hydrobromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Galantamine Hydrobromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Galantamine Hydrobromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Galantamine Hydrobromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Galantamine Hydrobromide suppliers with NDC on PharmaCompass.
Galantamine Hydrobromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Galantamine Hydrobromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Galantamine Hydrobromide GMP manufacturer or Galantamine Hydrobromide GMP API supplier for your needs.
A Galantamine Hydrobromide CoA (Certificate of Analysis) is a formal document that attests to Galantamine Hydrobromide's compliance with Galantamine Hydrobromide specifications and serves as a tool for batch-level quality control.
Galantamine Hydrobromide CoA mostly includes findings from lab analyses of a specific batch. For each Galantamine Hydrobromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Galantamine Hydrobromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Galantamine Hydrobromide EP), Galantamine Hydrobromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Galantamine Hydrobromide USP).
Market Place
